Your next licensing deal could positively transform your company’s value

With over 30 years of industry experience, constantly doing deals, from entering a transaction process through to deal structuring and negotiations, PharmaVentures can help you achieve the best licensing deals.

All you need to do is to speak with us. In recent years, we have enabled our clients to successfully transact assets worth more than $3Billion around the globe.

Dedicated Advisors

Adrian Dawkes​​
Managing Director
Phone: +44 (0) 7931 428 487

Stephen Waterman​
Managing Director
Phone: +44 (0) 7931 144 097

Kate Moore​
Vice President​
Phone: +44 (0) 7960 508 429

Expertise and knowledge

Top tier pharmaceutical companies, biotechs, diagnostics, medtech, healthcare IT and life science research companies, universities and technology transfer agencies have trusted​​ us to deliver the best licensing deals for their assets using our:

  • structured and proven licensing process, which starts well in advance of engaging with potential partners, to ensure a comprehensive and efficient approach to delivering successful deal outcomes
  • in-depth knowledge of timing, who to approach and how to tightly control transaction processes to facilitate each deal and give them the competitive edge to deliver premium value to clients
  • resource and capabilities to make their deal stand out from the competition in a crowded marketplace
  • extensive network, ensuring best access to potential partners for both licensors and licensees
  • globally experienced deal making team with relevant commercial, language and industry skill sets

Our Case Studies

European Biotech Licensing Transactions

A European biotech needed to licence a clinical phase compound to treat a CNS disease. PharmaVentures was chosen because its experience in valuing clinical development assets, marketing these and supporting the negotiations leading up to the closure of licensing deals.

How can we help you?

PharmaVentures offers a comprehensive solution to support you with strategic advice and successful deal outcomes for your company:

Acting to both out-license and in-license assets depending upon the requirements of our clients
Offering full-service business development and licensing support, valuable additional resources
Executing the entire process from building the proposition through to deal closure or any component part of the process – commercial and technical due diligence; asset valuation and positioning; target screening; financial modelling; deal structuring, comparables analysis, term sheet analysis and negotiation; deal closure
Understanding and managing practical and emotional challenges and facilitating political resolutions during the decision-making process around transactions
Coaching business development executives in effective negotiation and how to achieve best results

All FCA regulated activities are delivered through PharmaVentures Capital Limited, which is authorised and regulated by the Financial Conduct Authority (741356). PharmaVentures Capital Limited is a wholly owned subsidiary of Pharma Ventures Ltd. Past performance is not a guarantee of future performance. Information contained herein is for illustrative purposes only and should not be relied upon.

What Our Clients Say

“We were able to start licensing negotiations on several new products in a very short time period with the assistance of the highly professional and well organized experts from PharmaVentures.”

Multinational Pharmaceutical Company

Our Latest White Papers

Valuation Series: How to Interpret and Negotiate Deal Terms for a Life Science Licensing Agreement

This is the first in a series of white papers by the experts at PharmaVentures that explores the challenges of valuing drug candidates at various stages of clinical development.